FDA advisory panel gives thumbs-up to CBD epilepsy treatment

MJBizDaily
By Kevin HuhnApr 19, 2018, 1:41 pm
A CBD treatment for epilepsy is closer to becoming the first cannabis medicine approved for the U.S. market. A panel of government health advisers gave a unanimous recommendation Thursday to the U.S. Food and Drug Administration to approve Epidiolex, a CBD medicine for rare epilepsy conditions that don’t…

Read Article Share
Share Article
- email
- twitter
- facebook
- pocket
- reddit
- tumblr
- linkedin
- pinterest

Trending Today on NewsBudz

California: Lawmakers Advance Legislation to Governor’s Desk Halting Tax Hike on Commercially Available Cannabis Products 78

The Clock Is Ticking on Cannabis Rescheduling 74

PEI’s Retro Cannabis: from micro producer to standard licence 73

California Lawmakers Pass Bill to Undo Cannabis Industry Tax Hike 71

Massachusetts Lawmakers Approve Bill To Create Psychedelic Therapy Pilot Program 71

Another Minnesota Tribe Signs Agreement for Off-Reservation Cannabis Sales 67

Smoking Marijuana With A Water Bong Doesn’t Effectively Filter Compounds From Smoke, Study Suggests 64

NECANN NJ 2025 Cannabis Industry Convention Features New Cup of Champions 64

About NewsBudz

NewsBudz is your go-to app for daily cannabis news, covering everything from medical marijuana breakthroughs to recreational cannabis trends and legalization updates.

Our platform aggregates content from over 30 top-tier cannabis news outlets to deliver a curated stream of the latest headlines, insights, and developments across the marijuana and hemp industries.

Whether you're interested in policy reform, health research, cannabis business, CBD, delta 9 products or lifestyle stories, NewsBudz keeps you informed and connected. Accessible on the web and mobile, NewsBudz makes it easy to explore, read, and share cannabis news anytime, anywhere.